^E. R. Gaunt,1 A. Hardie,2 E. C. J. Claas,3 P. Simmonds,1 and K. E. Templeton. Epidemiology and Clinical Presentations of the Four Human Coronaviruses 229E, HKU1, NL63, and OC43 Detected over 3 Years Using a Novel Multiplex Real-Time PCR Method down-pointing small open triangle. J Clin Microbiol. 2010 August; 48(8): 2940–2947.
^Severance EG, Bossis I, Dickerson FB, et al. (2008). “Development of a nucleocapsid-based human coronavirus immunoassay and estimates of individuals exposed to coronavirus in a U.S. metropolitan population”. Clin Vaccine Immunol. doi:10.1128/CVI.00124-08. PMID18945884.
^Weimin Zhou 1, Wen Wang, Huijuan Wang, Roujian Lu, Wenjie Tan (2013). “First infection by all four non-severe acute respiratory syndrome human coronaviruses takes place during childhood”. BMC Infect Dis.13: 433. doi:10.1186/1471-2334-13-433. PMID3848659.
^ abK. A. Callow et al. (1990). “The time course of the immune response to experimental coronavirus infection of man.”. Epidemiol Infect.105 (2): 435–446. doi:10.1017/s0950268800048019. PMID2170159.
^ abArthur WD Edridge, et al. (2020). “Coronavirus protective immunity is short-lasting”. MedRxic. doi:10.1101/2020.05.11.20086439.
^Wevers, Brigitte A.; Van Der Hoek, Lia (2009). “Recently Discovered Human Coronaviruses”. Clinics in Laboratory Medicine29 (4): 715–24. doi:10.1016/j.cll.2009.07.007. PMID19892230.
^Mahony, James B. (2007). “Coronaviruses”. In Murray, Patrick R.; Baron, Ellen Jo; Jorgensen, James H. et al.. Manual of Clinical Microbiology (9th ed.). Washington D.C.: ASM Press. pp. 1414–23. ISBN978-1-55581-371-0
^Pyrc, K.; Berkhout, B.; Van Der Hoek, L. (2007). “Antiviral Strategies Against Human Coronaviruses”. Infectious Disorders Drug Targets7 (1): 59–66. doi:10.2174/187152607780090757. PMID17346212.
^Ana B Gorini da Veiga et al. (28 July 2020). “More than just a common cold: Endemic coronaviruses OC43, HKU1, NL63, and 229E associated with severe acute respiratory infection and fatality cases among healthy adults”. J Med Virol. doi:10.1002/jmv.26362. PMID32720706.
^Hélène Jacomy, Pierre J Talbot (2003 Oct 10). “Vacuolating encephalitis in mice infected by human coronavirus OC43”. Virology.315 (1): 20-33. doi:10.1016/s0042-6822(03)00323-4.
^Morfopoulou, Sofia; Brown, Julianne R.; Davies, E. Graham; Anderson, Glenn; Virasami, Alex; Qasim, Waseem; Chong, Wui K.; Hubank, Michael et al. (2016). “Human Coronavirus OC43 Associated with Fatal Encephalitis”. New England Journal of Medicine375 (5): 497–498. doi:10.1056/NEJMc1509458. ISSN0028-4793.
^N Arbour et al. (2000 Oct). “Neuroinvasion by human respiratory coronaviruses”. J Virol.74 (19): 8913-21. doi:10.1128/jvi.74.19.8913-8921.2000.
^R S Murray et al. (1992 May). “Detection of coronavirus RNA and antigen in multiple sclerosis brain”. Ann Neurol.31 (5): 525-33. doi:10.1002/ana.410310511.
^A Cristallo et al. (1997 Apr). “Human coronavirus polyadenylated RNA sequences in cerebrospinal fluid from multiple sclerosis patients”. New Microbiol.20 (2): 105-14. PMID9208420.
^F Lahrtz et al. (1998 May 1). “Chemokines and chemotaxis of leukocytes in infectious meningitis”. J Neuroimmunol.85 (1): 33-43.. doi:10.1016/s0165-5728(97)00267-1. PMID9626995.
^“Past Influenza pandemics and their effect in Malta”. Malta Medical Journal17 (3): 16–19. (2005). https://www.um.edu.mt/library/oar/handle/123456789/65125 March 2020閲覧. "1889-90 pandemic – The Asiatic Flu [...] by the end of March 1890. The case fatality rate approximated 4.0% [Table 1]. A resurgence of the infection became apparent in January-May 1892 with a total of 2017 reported cases and 66 deaths [case fatality rate 3.3%]"